Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
300.79
+2.50 (0.84%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Bio-Rad Laboratories stock have an average target of 301.25, with a low estimate of 275 and a high estimate of 320. The average target predicts an increase of 0.15% from the current stock price of 300.79.
Analyst Consensus: Hold
* Price targets were last updated on May 22, 2026.
Analyst Ratings
The average analyst rating for Bio-Rad Laboratories stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 3 | 3 | 3 | 3 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 4 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $290 → $310 | Hold | Maintains | $290 → $310 | +3.06% | May 22, 2026 |
| Jefferies | Jefferies | Hold Maintains $275 | Hold | Maintains | $275 | -8.57% | May 21, 2026 |
| RBC Capital | RBC Capital | Buy Initiates $320 | Buy | Initiates | $320 | +6.39% | May 14, 2026 |
| Citi | Citi | Hold Downgrades $375 → $300 | Hold | Downgrades | $375 → $300 | -0.26% | Apr 7, 2026 |
Financial Forecast
Revenue This Year
2.57B
from 2.58B
Decreased by -0.62%
Revenue Next Year
2.63B
from 2.57B
Increased by 2.63%
EPS This Year
9.00
from 9.92
Decreased by -9.25%
EPS Next Year
9.72
from 9.00
Increased by 7.99%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.6B | 2.7B | |
| Avg | 2.6B | 2.6B | |
| Low | 2.5B | 2.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.2% | 5.2% | |
| Avg | -0.6% | 2.6% | |
| Low | -2.0% | -1.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | 9.00 | 9.72 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -9.3% | 8.0% | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.